r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

HC

Helen Louise Collins

Insider · Chief Medical Officer · ELVN

Helen Louise Collins files insider transactions with the SEC as a chief medical officer of Enliven Therapeutics (ELVN). We hold 10 disclosed purchases and sales filed since 22 March 2017, 3 of them in the last 90 days.

  • Files forELVN
  • Disclosed buys and sells10 in all, 3 in the last 90 days
  • Last disclosure19 August 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 23 February 2023 — 17 August 2026Chief Medical Officer · Enliven Therapeutics (ELVN)70 Form 4 lines · source: SEC Form 4
  • Filed 28 July 2021 — 4 June 2026Director · Kura Oncology (KURA)7 Form 4 lines · source: SEC Form 4
  • Filed 15 November 2023 — 5 June 2025Director · IO Biotech (IOBT)3 Form 4 lines · source: SEC Form 4
  • Filed 20 March 2017 — 16 April 2021EVP and Chief Medical Officer · Five Prime Therapeutics (FPRX)48 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.